Medication Safety
Health Canada Recalls Femyso Lot Over Possible Duplicate Ingredient Cartons
Oct 30, 2026 · 3 min read Read briefingPhoto by pharmasist.ca
News & insight.
Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.
Practice Guidance
Manitoba’s Virtual-Care Direction Takes Effect for Pharmacists
Oct 30, 2026 · 3 min read Read briefingPhoto by pharmasist.ca
Regulatory Update
Manitoba Opens Consultation on Pharmacy Controlled-Substance Rules
Oct 30, 2026 · 3 min read Read briefingPhoto by pharmasist.ca
Drug Access
Pharmacy Plus PEI reaches four years with 309,500 assessments
Oct 30, 2026 · 3 min read Read briefingDrug Access
Manitoba’s Nov. 1 formulary changes add Dexcom G7 15-day sensors and new drug listings
Oct 30, 2026 · 3 min read Read briefingDrug Access
Nuvaxovid returns for Canada’s 2026–27 COVID season, but pharmacy access varies
Oct 30, 2026 · 3 min read Read briefingPharmacy Services
Shoppers Drug Mart reports 1.7 million minor-ailment visits, but comparison questions remain
Oct 30, 2026 · 4 min read Read briefingIncident Report
Hamilton police renew appeal after August robbery at Stoney Creek pharmacy
Oct 30, 2026 · 3 min read Read briefingDrug Access
Health Canada adds five ingredients to the Prescription Drug List
Oct 30, 2026 · 3 min read Read briefing
Medication Safety
Health Canada joins Nov. 2–8 campaign urging reports of suspected side effects
Oct 30, 2026 · 3 min read Read briefingImage: Health Canada — #MedSafetyWeek 2026 campaign banner (Canada.ca)
Regulatory Update
Manitoba Bill 240 proposes broader pharmacist prescribing authority
A private member’s bill would authorize pharmacists to prescribe designated drugs for a wider list of minor conditions, but regulations, safeguards and a delayed start date would still be required.
Oct 23, 2026 · 4 min read Read briefingPhoto: National Cancer Institute via Unsplash. Source: Image source
Drug Access
pCPA completes ELAHERE negotiations; public-plan decisions still ahead
The pan-Canadian Pharmaceutical Alliance lists ELAHERE negotiations as concluded with a letter of intent, after AbbVie announced the agreement on October 21. The milestone moves the drug closer to possible public reimbursement, but provincial and territorial plan listings still follow.
Oct 23, 2026 · 3 min read Read briefingPhoto: National Cancer Institute via Unsplash. Source: Image source